The Truth About Peptides, TRT and the Ozempic Boom - EP 314

I sat down with Tony Whatley on the 365 Driven Podcast for a long, wide-open conversation and we ended up covering everything from my early years as a physician working in the California prison system, to walking away from the golden handcuffs to build a med spa company, all the way to the stuff everyone's whispering about right now: peptides, hormone therapy and the GLP-1 weight loss boom.

If you've been curious what's real and what's hype in the wellness world, this is the honest version from someone who actually runs these treatments at scale, not a guru trying to sell you a protocol.

On peptides, here's the truth I gave Tony. Peptides are just amino acids arranged in a specific chain and that chain flips a switch in your body, one might trigger more growth hormone production, another affects inflammation, another does something else entirely. Because they work through your body's own pathways instead of being anabolic like a steroid, they can be much safer, but there's a real catch: a lot of them are untested, the quality varies wildly and the FDA recently recategorized many that used to be legally compounded. So the "peptides fix everything" wave online has turned into the next get-rich-quick guru space and you have to know the difference between what's legitimate and what's hype.

On hormones and TRT, my take is that what most people write off as a midlife crisis is very often just a hormone imbalance. Entrepreneurs get exhausted, foggy, moody, lose their drive and reach for the wrong fixes. Getting your hormones checked and balanced can do more for your sleep, focus, mood and sex life than a lot of the medications people get put on by default. You should not simply accept losing your energy and desire as you age.

On the Ozempic boom, I break down the GLP-1 landscape, semaglutide and tirzepatide and why this is only the beginning. There's going to be a new, better weight loss drug essentially every year for the next several years because they're already deep in FDA trials. This category isn't a fad, it's a fundamental shift in how metabolic health gets treated.

We also get into the business side that made all of this possible: how I scaled through acquisition, why you should never buy a business whose core values don't match yours, why there's no such thing as passive income in acquisitions and the mindset that pulled me out of the golden-handcuffs trap that quietly crushes so many high earners.

This one is part business, part health and all str